PETS
Price
$1.25Alerts
Change
+$0.03 (+2.46%)
Updated
Nov 9 closing price
Capitalization
26.45M
Earnings call today
Intraday BUY SELL Signals
SCNX
Price
$3.20Alerts
Change
+$0.06 (+1.91%)
Updated
Nov 9 closing price
Capitalization
128.94M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PETS vs SCNX

PETS vs SCNX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PETS vs. SCNX commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PETS is a Hold and SCNX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PETS with price predictions
Nov 09, 2026

PETS's Stochastic Oscillator is staying in overbought zone for 1 day

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PETS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

PETS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PETS entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PETS's RSI Oscillator exited the oversold zone, 33 of 48 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on PETS as a result. In 71 of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for PETS just turned positive on October 20, 2026. Looking at past instances where PETS's MACD turned positive, the stock continued to rise in 27 of 46 cases over the following month. The odds of a continued upward trend are 59%.

Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where PETS advanced for three days, in 144 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.151) is normal, around the industry mean (1.378). P/E Ratio (-0.891) is within average values for comparable stocks, (-2.174). Projected Growth (PEG Ratio) (1.270) is also within normal values, averaging (0.947). PETS has a moderately high Dividend Yield (0.984) as compared to the industry average of (0.246). P/S Ratio (0.200) is also within normal values, averaging (2.504).

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. PETS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PETS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

A.I.Advisor
a Summary for SCNX with price predictions
Nov 09, 2026

SCNX saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for SCNX moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 25 similar instances where the indicator exited the overbought zone. In 23 of the 25 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for SCNX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SCNX's RSI Indicator exited the oversold zone, 31 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on SCNX as a result. In 64 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for SCNX just turned positive on October 20, 2026. Looking at past instances where SCNX's MACD turned positive, the stock continued to rise in 37 of 41 cases over the following month. The odds of a continued upward trend are 90%.

Following a +3.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCNX advanced for three days, in 172 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. SCNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.012) is normal, around the industry mean (1.378). P/E Ratio (-1.547) is within average values for comparable stocks, (-2.174). SCNX's Projected Growth (PEG Ratio) (0.480) is slightly lower than the industry average of (0.947). Dividend Yield (0.000) settles around the average of (0.246) among similar stocks. SCNX's P/S Ratio (11.779) is slightly higher than the industry average of (2.504).

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

FUNDAMENTALS RATINGS
PETS vs SCNX: Fundamental Ratings
PETS
SCNX
OUTLOOK RATING
1..100
135
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
7991
P/E GROWTH RATING
1..100
1398
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PETS's Valuation (4) in the Drugstore Chains industry is significantly better than the same rating for SCNX (97) in the null industry. This means that PETS’s stock grew significantly faster than SCNX’s over the last 12 months.

PETS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as SCNX (100) in the null industry. This means that PETS’s stock grew similarly to SCNX’s over the last 12 months.

PETS's SMR Rating (98) in the Drugstore Chains industry is in the same range as SCNX (98) in the null industry. This means that PETS’s stock grew similarly to SCNX’s over the last 12 months.

PETS's Price Growth Rating (79) in the Drugstore Chains industry is in the same range as SCNX (91) in the null industry. This means that PETS’s stock grew similarly to SCNX’s over the last 12 months.

PETS's P/E Growth Rating (13) in the Drugstore Chains industry is significantly better than the same rating for SCNX (98) in the null industry. This means that PETS’s stock grew significantly faster than SCNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PETSSCNX
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
64%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
84%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (PETS: $1.25 vs. SCNX: $3.20)
Brand notoriety: PETS and SCNX are both not notable
Both companies represent the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: PETS: 86% vs. SCNX: 20%
Market capitalization -- PETS: $26.45M vs. SCNX: $128.94M
PETS [@Drugstore Chains] is valued at $26.45M. SCNX’s [@Drugstore Chains] market capitalization is $128.94M. The market cap for tickers in the [@Drugstore Chains] industry ranges from $36.55K to $14.27B. The average market capitalization across the [@Drugstore Chains] industry is $82.05M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PETS’s FA Score shows that 2 FA rating(s) are green while SCNX’s FA Score has 0 green FA rating(s).

  • PETS’s FA Score: 2 green, 3 red.
  • SCNX’s FA Score: 0 green, 5 red.
According to our system of comparison, PETS is a better buy in the long-term than SCNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PETS’s TA Score shows that 4 TA indicator(s) are bullish while SCNX’s TA Score has 4 bullish TA indicator(s).

  • PETS’s TA Score: 4 bullish, 4 bearish.
  • SCNX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SCNX is a better buy in the short-term than PETS.

Price Growth

PETS (@Drugstore Chains) experienced а +4.17% price change this week, while SCNX (@Drugstore Chains) price change was -0.93% for the same time period.

The average weekly price growth across all stocks in the @Drugstore Chains industry was +5.54%. For the same industry, the average monthly price growth was +20.25%, and the average quarterly price growth was -31.58%.

Reported Earning Dates

PETS is expected to report earnings on Nov 10, 2026.

SCNX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Drugstore Chains (+5.54% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

PETS and

Correlation & Price change

A.I.dvisor tells us that PETS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PETS and LFMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PETS
1D Price
Change %
PETS100%
+2.46%
LFMD - PETS
22%
Poorly correlated
-11.60%
HITI - PETS
22%
Poorly correlated
-0.38%
YI - PETS
19%
Poorly correlated
+2.05%
SCNX - PETS
5%
Poorly correlated
+1.91%
LFMDP - PETS
5%
Poorly correlated
-1.55%
More

SCNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNX has been loosely correlated with HKPD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SCNX jumps, then HKPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNX
1D Price
Change %
SCNX100%
+1.91%
HKPD - SCNX
39%
Loosely correlated
+6.76%
LFMD - SCNX
22%
Poorly correlated
-11.60%
HITI - SCNX
20%
Poorly correlated
-0.38%
POM - SCNX
7%
Poorly correlated
-14.36%
RDGT - SCNX
6%
Poorly correlated
+13.00%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KDK1.450.17
+13.28%
Kodiak AI Inc
GDRX3.650.14
+3.99%
GoodRx Holdings
CMCSA24.510.12
+0.49%
Comcast Corp
TAL10.190.03
+0.30%
TAL Education Group
PSHG1.99-0.09
-4.33%
Performance Shipping